Mumbai, 11 Nov 2013: Over 60 drug manufacturers have agreed to increase trade margins of wholesalers and retailers on price controlled medicines after a series of talks between various industry bodies and All India Organisation of Chemists and Druggists (AIOCD). AIOCD had to initiate talks with the industry bodies as Department of Pharmaceuticals (DoP) has been hesitant to restore the old trade margins by amending DPCO 2013. Says Suresh Gupta, general secretary, AIOCD, "We look forward to getting an increase in the trade margin from over 90 companies for which talks are still going on." |
Monday, November 11, 2013
60 drug cos offer increased margins to trade on controlled drugs after talks with AIOCD
Saturday, November 9, 2013
DoP asks NPPA to relook at ceiling price fixed for azithromycin under new DPCO
New Delhi, 31 Oct 2013: The National Pharmaceutical Pricing Authority (NPPA) has been directed by the Department of Pharmaceuticals (DoP) to reconsider the ceiling price fixed for Zithrox and Azilide brands of azithromycin produced by Alembic Pharmaceuticals Ltd., following a review petition filed by the company against the NPPA revision as per the new Drug Price Control Order, 2013. However, the review petitions by Modi-Mundipharma Pvt Ltd and Win-Medicare Pvt Ltd were rejected by the DoP as many more companies have reportedly challenged the new ceiling prices announced by the NPPA in line with the DPCO and the pharmaceutical pricing policy in the recent months. |
After HC disallows ban, govt to put warning on anti-depressant
New Delhi, 6 Nov 2013: Left red-faced after yet another drug ban order failed to pass judicial scrutiny, the government is set to pass an order that anti-depressant Deanxit should be sold with a warning in red that the drug is to be sold only on the prescription of a registered psychiatrist. A notification regarding this will soon be issued under section 26A of the Drugs and Cosmetics Act. In addition, an expert committee comprising psychiatrists and pharmacologists constituted by the Drug Technical Advisory Board will examine the safety and efficacy of the drug and make recommendations about its marketing in India. |
SHRI K.E.PRAKASH PRESIDENT KCDA AT.............
On this occasion Shri Rajshekhar Malli (Asst.Drugs Controller of Belgaum circle) and Shri K.S.Mallikarjun(Asst.Drugs Controller of Karwar cicle) will guide about the amendments in Drugs & Cosmetics rules.
Talking with Belgaum Chemist Blog,Shri Gangadhar Turmundi,Secretary of the Association briefed the Successful Activities of the Association,like Solving problems of wholesale distributors,Retail Members.Also by circulating Important circulars about Rules& Regulations of Drug & Cosmetic Act 1940,Vat circulars time to time.In coming days Association is arranging Education Programmes for their Members.
Monday, October 7, 2013
More large pharma cos offer higher trade margins over DPCO 2013
Mumbai, 28 Sept 2013: Shortage of essential medicines on retail shelves may be over soon as nine pharma companies in succession over the past two months have agreed to offer higher margins to the retailers and stockists against what has been mandated in the DPCO-2013. AIOCD has been in the process of approaching over 100 companies with similar demands over the past couple of months. Taking cue from Mumbai-based Blue Cross Laboratories Ltd, Franco-Indian Pharmaceuticals Pvt Ltd, RPG Life Sciences, Delcure Life Sciences and Modi Mundipharma, Mumbai based Macleods Pharmaceuticals Ltd, Hetero Healthcare Ltd, Indoco Remedies Ltd and FDC Ltd will also offer higher margins of 20 per cent and 10 per cent to retailers and stockists respectively as demanded by trade body All India Organisation of Chemists and Druggists (AIOCD). |
Parliamentary panel starts scrutiny of Drugs & Cosmetics (Amendment) Bill, 2013
New Delhi, 30 Sept 2013: The Parliamentary Standing Committee on Health and Family Welfare has started examining the new Drugs and Cosmetics (amendment) Bill, 2013 which was presented in the Rajya Sabha last month, seeking to centralise the licensing system in 17 categories of drugs. The Panel headed Brajesh Pathak is learnt to have already kicked off the process and took the views of the Secretary of the Department of Health and Family Welfare recently, after the bill was referred to the committee by the Rajya Sabha. |
New drug pricing policy under SC scanner
New Delhi, 4 Oct 2013: The government's new drug pricing policy came under the scanner Thursday as the Supreme Court sought an explanation over the latest pricing formula for essential medicines and questioned if market driven forces had an effect on it. A Bench led by Justice G S Singhvi said it will "test" the rationale behind the new Drug Price Control Order to fix the ceiling price of essential medicines on the basis of average market-based pricing. It demanded an answer on why the new policy, which intends to put a cap on prices of 348 medicines, changed the formula for deciding the cap from a cost-based mechanism to a market price-based mechanism. |
Subscribe to:
Posts (Atom)